According to the research report, the Global AI in Clinical Trials Market was valued at $1.8 Billion in 2022, and is projected to reach a market size of $8.27 Billion by 2030. The market is projected to grow with a CAGR of 21% per annum during the period of analysis (2023 - 2030)
Industry Overview:
Artificial intelligence (AI) has emerged as a significant tool for improving clinical trial operating efficiency, speeding drug discovery and development, and lowering trial costs. This technology can assist pharmaceutical and biotech businesses in overcoming a variety of challenges in clinical trials and the drug development process. To collect and evaluate the enormous amounts of data that fuel current therapeutic development, AI-powered data integration and pattern recognition are required. Over the projected period, increasing awareness of the benefits of AI-based clinical trials is likely to drive global revenue growth. Wearable technology, along with AI approaches, may also be used to keep track of patients throughout clinical trials in a real-time, customized, and continuous manner. This can improve patient adherence to the procedure as well as the dependability of the system.
Other factors driving market revenue growth include an increase in the number of clinical studies and increased government and private attempts to improve healthcare facilities by adopting innovative AI technology and drugs. However, expensive research and development costs, a scarcity of trained experts, an understanding of how to employ complex AI algorithms, and strict government regulations on drug development are all issues that might limit the market's revenue growth throughout the projected period.
Impact of Covid-19 on the Industry:
Major pharmaceutical corporations are putting money into artificial intelligence-based technologies as part of strategic strategies to aid with drug development during and after a pandemic. AI-based solutions are useful not only for assessing the drug development process for a variety of therapeutic uses but also for detecting COVID-19 and developing a vaccine. As a result of the pandemic, AI applications for virtual screening of novel chemical entities and repurposed medication candidates have grown in popularity. The COVID-19 pandemic has shifted the focus of pharmaceutical companies, academia, contract research organizations (CROs), and others away from the traditional drug development process and toward the importance of AI-based solutions for improving clinical outcomes, lowering costs, and shortening clinical trial times. In this market, decentralized clinical trials (DCT) are gaining pace, owing to a move toward virtual or telehealth-based clinical trials in 2020. For example, concrete, a provider of AI-based clinical trial solutions, has seen an increase in the utilization of their solution for DCT cancer studies.
Market Drivers:
Artificial intelligence (AI) will continue to infiltrate the industry, propelling it forward:
The market for AI-based clinical trial solution providers is being propelled by factors such as rising artificial intelligence (AI) penetration, growing acceptance of AI-sourced machinery among academics and pharmaceutical manufacturing companies, and beneficial private and public sector projects for R&D on a variety of curative subjects. The expansion is further aided by raising awareness and the numerous services provided by artificial intelligence (AI) in the field of clinical trials. A shift in attitude by major pharmaceutical corporations from the traditional way of drug creation to a technology-based strategy is also propelling industry expansion.
Many companies are taking a positive approach toward AI adoption:
For the course of the projection, these organizations’ positive approach toward the deployment of AI-sourced equipment in clinical trials as well as in general medicine detection and improvement is predicted to boost the growth of the AI-based clinical trials solution provider market.
Market Restraints:
Lack of personal involvement leads to a rise in unemployment rates:
The increasing adoption of artificial intelligence will be leading to an increasing rate of unemployment in the nation. The development of artificial intelligence comes with increasing concern over the unemployment of both skilled and unskilled labor.
Possibilities of Defective Diagnosis will act as a market restraint:
Even though technological advancement has improved over the years, still we cannot rely on technology. Artificial Intelligence is still under development which makes it less reliable as compared to trained professional doctors who have years of experience in the field.
GLOBAL AI IN CLINICAL TRIALS MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2022 - 2030 |
|
Base Year |
2022 |
|
Forecast Period |
2023 - 2030 |
|
CAGR |
21% |
|
Segments Covered |
By Clinical Trial Phase, Application, End User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
IBM Watson, Google-Verily, Euretos, Trials.Ai, Pharmaseal, DEEP LENS AI, AiCure, LLC, Symphony AI, Intelligencia, Innoplexus, Phesi, Saama Technologies, Exscientia, GNS Healthcare |
This research report on the global digital migraine therapeutics market has been segmented and sub-segmented based on Offering, Application, Geography & region.
Phase-I
Phase-II
Phase-III
In 2020, the phase-II sector dominated the AI-based clinical trials solution provider market with a 48.5 percent revenue share. The increased number of clinical trial actions in the second phase is responsible for this higher percentage. Furthermore, during the projected period, the Phase-I sector is predicted to develop at the fastest rate. Since the first phase, the use of AI-based solutions and technologies has been beneficial in terms of retention, enhanced test design, and patient enrolment. As a result, its adoption is predicted to increase during the projection period, implying a significant rate of expansion.
Oncology
Cardiovascular Diseases
Neurological Diseases or Conditions
Metabolic Diseases
Infectious Diseases
Others
Because of the increasing occurrences of cancer and the rising number of clinical trials, the oncology sector had the largest, 24.0 percent revenue share, and dominated the artificial intelligence-based clinical trials solution provider market, based on therapeutic applications, in 2020. Furthermore, during the projection period, the neurological illnesses or conditions area is expected to have the highest CAGR. The most important variables attributed to superior enlargement are the increased prevalence of neurological problems and the growing number of clinical studies in the arena.
Pharmaceutical Companies
Academia
Others
Because of the increased acceptance of AI-sourced machinery for clinical trials and drug development by prominent pharmaceutical firms, the pharmaceutical businesses division led the market with a 66.9% revenue share in 2020. Tactical plans in the form of joint ventures, mergers and acquisitions, and alliances are also aiding market progress. In addition, throughout the predicted period, the others segment is anticipated to have the highest CAGR. The growing use of artificial intelligence (AI) by pharmaceutical businesses, as well as a rising trend of other institutions such as government organizations, Contract Research Organizations (CROs), and others, are driving the section's growth.
North America
Europe
Asia-Pacific
Latin America
The Middle East and Africa
North America dominated the worldwide AI-based clinical trials solution provider market with a 43.6 percent revenue share in 2020. This growth can be attributed to several factors, including increased awareness of AI-sourced technologies and tools, an increase in the number of start-ups in the region that support artificial intelligence (AI) in drug development, and increased implementation of AI-sourced technologies, and an increase in the number of clinical trials. Furthermore, positive government policies and growing tactical programs by large corporations are driving the demand for AI-based clinical trial solutions in the area.
Furthermore, the market in the Asia Pacific is expected to expand profitably during the projected period, owing to the rising penetration of AI-based technologies inside the area. Furthermore, the government's encouraging leadership in raising awareness and adoption of artificial intelligence (AI) in many healthcare fields, as well as medication development and improvement, are likely to drive market expansion throughout the projection period.
Global AI Clinical Trials Market- By Companies
IBM Watson
Google-Verily
Euretos
Trials.Ai
Pharmaseal
DEEP LENS AI
AiCure, LLC
Symphony AI
Intelligencia
Innoplexus
Phesi
Saama Technologies
Exscientia
GNS Healthcare
NOTABLE HAPPENINGS IN THE GLOBAL AI IN CLINICAL TRIALS MARKET MARKET IN THE RECENT PAST.
Business Partnership: - In March 2021, through Saama's Life Science Analytics Cloud, Datavant and Saama Technologies, Inc. have formed a partnership to map patient journeys across a variety of real-world and clinical datasets (LSAC). Over the projection period, such initiatives are projected to enhance the usage of AI-based solutions.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
